saplin

UTI Focused Fund (30 stocks)

UTI Focused Fund (30 stocks) (Direct, Growth): saplin Score 5.9/10 (Weak) among 28 Focused funds. 3Y return 12.3% a year vs 14.5% category median, expense ratio 1.13%. Uneven returns hold this fund back. NAV ₹17.36 on 11 Nov 2026.

Loading the full analysis…

Questions about UTI Focused Fund (30 stocks)

What is the expense ratio of UTI Focused Fund (30 stocks)?

The Direct plan's total expense ratio is 1.13% a year, against a median of 1.08% for focused funds. The Regular plan costs more because it pays a distributor's commission.

Who manages UTI Focused Fund (30 stocks)?

Vishal Chopda (since 2 May 2022).

What are the top holdings of UTI Focused Fund (30 stocks)?

ICICI Bank 8.43%, HDFC Bank 7.76%, Eternal 5.85%, Reliance Industries 5.82%, Bharti Airtel 5.27% of the portfolio, as of 31 Oct 2026.

What returns has UTI Focused Fund (30 stocks) given?

1 year: 3.0% (category median 4.0%); 3 years: 12.3% a year (category median 14.5%); 5 years: 10.4% a year (category median 11.3%). Past returns do not predict future ones.

How big is UTI Focused Fund (30 stocks)?

About ₹2,451 cr (AMFI's average for the latest quarter).

How does UTI Focused Fund (30 stocks) score?

5.9 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on UTI Focused Fund (30 stocks)